Psychedelic Science Newsletter
Issue #21January 20, 20267 studies

LSD microdoses boost reward processing in depressed brains — while firefighters face barriers to ketamine PTSD treatment

This week brought fascinating insights into how psychedelics affect the brain differently based on mental health status, plus sobering realities about treatment access for those who need it most.

🧠 LSD Microdoses Rewire Reward Processing—But Only in Depressed Brains

  • 20 participants with mild-to-moderate depression got tiny doses of LSD (26 μg) and showed enhanced brain responses to losing money—suggesting their brains were processing emotional rewards more intensely

  • The effect was specific: LSD only changed reward-related brain activity in depressed participants, not in the 19 healthy controls

  • Those who had stronger brain responses to LSD also reported better moods immediately after treatment and lower depression scores 48 hours later

Why it matters: This suggests LSD microdoses may work by helping depressed brains pay more attention to emotional experiences, potentially explaining why some people report mood benefits from tiny psychedelic doses.

🎖️ Top 10% journal 🔗 Journal of psychopharmacology (Oxford, England) Journal Article 🗓️ Jan 13

Key Findings

🚒 Firefighters Hit Roadblocks Getting Ketamine for PTSD

  • 6 firefighters enrolled in a ketamine-assisted therapy program but couldn't start treatment due to barriers like stigma, financial costs, and complex logistics

  • Firefighters face PTSD rates of 7.3% compared to just 1.3-3.5% in the general population, yet struggle with both workplace stigma around mental health and skepticism about ketamine treatment

  • Self-advocacy emerged as crucial—firefighters had to navigate insurance, find providers, and manage scheduling around demanding work shifts

💡 System-wide changes may be needed to help high-risk professions access promising PTSD treatments.

🔬 Ketamine Withdrawal Scrambles Memory in Young Female Rats

  • Adolescent female rats given recreational doses of ketamine (10 mg/kg for 3 days) showed impaired episodic, social, and working memory 24 hours after their last dose

  • Brain analysis revealed significantly reduced serotonin and norepinephrine levels in the hippocampus and prefrontal cortex during withdrawal

  • The study mimicked weekend party use patterns, suggesting even short-term recreational ketamine use may disrupt multiple memory systems

💡 Recreational ketamine use during adolescence may carry cognitive risks that persist beyond the immediate drug effects.
Top 20% journal 🔗 Behavioural brain research Journal Article 🗓️ Jan 18

📊 Nearly Half of Synthetic Drug Seizures Turn Deadly

  • A review of 42 cases found that seizures from synthetic cathinones and phenethylamines (designer stimulants) resulted in death in nearly 50% of cases

  • Beyond the expected serotonin toxicity, many fatal cases involved preventable complications like brain hemorrhage, cerebral swelling, low blood sugar, and dangerously low sodium levels

  • Most victims were previously healthy young adults, suggesting these complications might be treatable if recognized early

💡 Emergency responders may be able to save more lives by checking for treatable metabolic problems alongside standard overdose protocols.
Top 20% journal 🔗 Neurotoxicology Journal Article 🗓️ Jan 16

⚡ Lithium Tops List for Preventing Depression Relapse After Electroshock

  • A review of 28 studies covering 11,119 patients found lithium (alone or with antidepressants) most consistently prevented depression from returning after successful electroconvulsive therapy

  • Continuation ECT combined with medication also showed strong evidence for preventing relapse across multiple randomized trials

  • Only 2 studies examined psychotherapy for relapse prevention, revealing a major research gap despite about 50% of patients relapsing within a year

💡 The evidence strongly supports specific medications for maintaining ECT benefits, but psychological approaches remain understudied.
🎖️ Top 10% journal 🔗 BJPsych open Review 🗓️ Jan 14

🎯 Ketamine-Induced Brain States Mirror PTSD Patterns

  • 30 healthy volunteers given ketamine showed brain network changes resembling those seen in 78 PTSD patients—specifically increased default mode network activity and decreased somatomotor network activity

  • PTSD patients who improved after treatment showed reduced default mode network dominance, correlating with fewer dissociative symptoms

  • The similarity suggests dissociation may involve specific, measurable brain network patterns regardless of whether it's drug-induced or trauma-related

💡 Understanding how ketamine creates dissociation may help researchers develop better treatments for trauma-related dissociative symptoms.
🎖️ Top 10% journal 🔗 Biological psychiatry global open science Journal Article 🗓️ Jan 19

🧪 Portuguese Hospital Tests Ketamine-Psychotherapy Combo

  • All 9 patients with treatment-resistant depression improved after 8 weeks of ketamine infusions plus psychotherapy, with depression scores shifting from severe to moderate levels

  • 44% of patients showed strong responses (≥50% reduction in depression scores), and over half of those with suicidal thoughts saw those symptoms disappear

  • Only 29% of patients experienced mood deterioration within 3 months after treatment ended, suggesting relatively durable benefits

💡 Combining ketamine with psychotherapy may offer hope for severe depression cases in standard hospital settings.
Top 20% journal 🔗 Brain and behavior Journal Article 🗓️ Jan 13

Implications

This week's research reveals how psychedelics and related treatments work differently depending on individual brain states and mental health conditions. While the science shows promise—from LSD's selective effects in depression to ketamine's potential for severe cases—real-world implementation faces significant barriers around access, safety monitoring, and long-term support systems.

Studies in this issue

Primary sources used for this newsletter.

  1. Brain reward system activity after low doses of LSD in people with depressed mood
    main storyJournal of psychopharmacology (Oxford, England)2026-01-13PMID 41529826
  2. Triggers of Deadly Seizures Caused by New Synthetic Stimulant Drugs
    key findingNeurotoxicology2026-01-16PMID 41544778
  3. Challenges Firefighters Face Getting Ketamine Therapy for PTSD
    key findingJournal of Occupational and Environmental Medicine2026-01-16PMID 41540564